Group 1 - The chemical pharmaceutical sector experienced a decline of 1.52% on December 29, with Hongyuan Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] - Notable gainers in the chemical pharmaceutical sector included Duorui Pharmaceutical, which rose by 9.89%, and Yahui Pharmaceutical, which increased by 4.61% [1] Group 2 - Hongyuan Pharmaceutical saw a significant drop of 10.97%, closing at 23.93, with a trading volume of 598,100 shares and a transaction value of 1.442 billion yuan [2] - Other notable decliners included Xintai, down 9.97%, and Suwu, down 9.38% [2] - The sector experienced a net outflow of 2.25 billion yuan from major funds, while retail investors saw a net inflow of 1.48 billion yuan [2] Group 3 - Among individual stocks, Yahui Pharmaceutical had a net inflow of 40.30 million yuan from major funds, while HaiXiang Pharmaceutical had a net inflow of 39.15 million yuan [3] - Retail investors showed a net outflow from several stocks, including Yahui Pharmaceutical and HaiXiang Pharmaceutical, indicating a mixed sentiment in the market [3] - The overall trading activity in the sector reflects a cautious approach from institutional investors, contrasted by retail investor participation [3]
化学制药板块12月29日跌1.52%，宏源药业领跌，主力资金净流出22.5亿元